Valneva SE (EPA:VLA)
France · Delayed Price · Currency is EUR 4.024
-0.276 (-6.42%)
At close: Nov 28, 2025
Valneva SE Market Cap
Valneva SE has a market cap or net worth of €691.04 million as of November 28, 2025. Its market cap has increased by 100.94% in one year.
Market Cap
691.04M
Enterprise Value
743.42M
Revenue
179.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.02
Market Cap Chart
Since June 29, 2007, Valneva SE's market cap has increased from 99.08M to 691.04M, an increase of 597.47%. That is a compound annual growth rate of 11.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 691.04M | 96.82% |
| Dec 31, 2024 | 351.10M | -46.40% |
| Dec 29, 2023 | 655.08M | -23.93% |
| Dec 30, 2022 | 861.12M | -66.55% |
| Dec 31, 2021 | 2.57B | 265.20% |
| Dec 31, 2020 | 704.92M | 201.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 144.39B |
| Sanofi | 104.35B |
| Sartorius Stedim Biotech | 19.75B |
| bioMérieux | 12.90B |
| Eurofins Scientific SE | 10.50B |
| Ipsen | 10.22B |
| ABIVAX Société Anonyme | 8.45B |
| Virbac | 3.09B |